Boundless Bio Stock

Boundless Bio EBIT per Share

The EBIT per Share of Boundless Bio (BOLD) as of Sep 5, 2026 is -4.31 USD. In the previous year, EBIT per Share was -2.46 USD — a change of 75.08% (lower).

EBIT per Share

-4.31USD

YoY

75.08%

Last updated:

EBIT per Share of Boundless Bio is 2026 -4.31 USD. EBIT per Share of Boundless Bio was 2025 -2.46 USD. It decreases by 75.08% lower compared to the previous year.

The Boundless Bio EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
-2.46 USD
Jan 1, 2024
-4.31 USD
Jan 1, 2025 (e)
-3.73 USD
Jan 1, 2026 (e)
-3.34 USD
Jan 1, 2027 (e)
-3.30 USD
Jan 1, 2028 (e)
-3.42 USD
Jan 1, 2029 (e)
-1.20 USD
Jan 1, 2030 (e)
1.26 USD
The Boundless Bio EBIT per Share history
YEAREBIT per ShareYoY
est1.26USD-205.00%
est-1.20USD-64.91%
est-3.42USD+3.88%
est-3.30USD-1.32%
est-3.34USD-10.50%
est-3.73USD-13.50%
-4.31USD+75.08%
-2.46USD+17.92%
-2.09USD+83.66%
-1.14USD—
Access this data via the Eulerpool API
Get Free API Key

Boundless Bio Stock analysis

What does Boundless Bio do? Boundless Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Boundless Bio stock

EBIT per Share of Boundless Bio is -4.31 USD in 2026.

EBIT per Share of Boundless Bio changed from -2.46 USD to -4.31 USD, representing a 75.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Boundless Bio since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Boundless Bio

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Boundless Bio